IL92102A - Renin-inhibitory peptides containing difluoromethylene amide bond replacements, process for their preparation and pharmaceutical compositions containing them - Google Patents

Renin-inhibitory peptides containing difluoromethylene amide bond replacements, process for their preparation and pharmaceutical compositions containing them

Info

Publication number
IL92102A
IL92102A IL9210289A IL9210289A IL92102A IL 92102 A IL92102 A IL 92102A IL 9210289 A IL9210289 A IL 9210289A IL 9210289 A IL9210289 A IL 9210289A IL 92102 A IL92102 A IL 92102A
Authority
IL
Israel
Prior art keywords
methyl
compound
val
amino acid
groups
Prior art date
Application number
IL9210289A
Other languages
English (en)
Other versions
IL92102A0 (en
Original Assignee
Merrell Dow Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharma filed Critical Merrell Dow Pharma
Publication of IL92102A0 publication Critical patent/IL92102A0/xx
Publication of IL92102A publication Critical patent/IL92102A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06—Esters of carbamic acids
    • C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
    • C07C271/10—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C271/20—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by nitrogen atoms not being part of nitro or nitroso groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06—Esters of carbamic acids
    • C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
    • C07C271/10—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C271/16—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by singly-bound oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06—Esters of carbamic acids
    • C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
    • C07C271/10—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C271/18—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by doubly-bound oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06—Esters of carbamic acids
    • C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
    • C07C271/10—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C271/22—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by carboxyl groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/021—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-(X)n-C(=0)-, n being 5 or 6; for n > 6, classification in C07K5/06 - C07K5/10, according to the moiety having normal peptide bonds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06191—Dipeptides containing heteroatoms different from O, S, or N
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0827—Tripeptides containing heteroatoms different from O, S, or N
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14—The ring being saturated

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Luminescent Compositions (AREA)
  • Peptides Or Proteins (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Measurement And Recording Of Electrical Phenomena And Electrical Characteristics Of The Living Body (AREA)
  • Radio Relay Systems (AREA)
  • Measuring Pulse, Heart Rate, Blood Pressure Or Blood Flow (AREA)
  • Pyridine Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Inspection Of Paper Currency And Valuable Securities (AREA)
IL9210289A 1988-10-28 1989-10-24 Renin-inhibitory peptides containing difluoromethylene amide bond replacements, process for their preparation and pharmaceutical compositions containing them IL92102A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP88402735A EP0371179A1 (fr) 1988-10-28 1988-10-28 Analogues des substrats de peptidases

Publications (2)

Publication Number Publication Date
IL92102A0 IL92102A0 (en) 1990-07-12
IL92102A true IL92102A (en) 1994-07-31

Family

ID=8200435

Family Applications (1)

Application Number Title Priority Date Filing Date
IL9210289A IL92102A (en) 1988-10-28 1989-10-24 Renin-inhibitory peptides containing difluoromethylene amide bond replacements, process for their preparation and pharmaceutical compositions containing them

Country Status (18)

Country Link
US (1) US5114927A (fr)
EP (2) EP0371179A1 (fr)
JP (1) JP2899327B2 (fr)
CN (1) CN1031880C (fr)
AT (1) ATE147405T1 (fr)
AU (1) AU622723B2 (fr)
CA (1) CA2001265C (fr)
DE (1) DE68927630T2 (fr)
DK (1) DK537589A (fr)
ES (1) ES2099072T3 (fr)
FI (1) FI95272C (fr)
GR (1) GR3023027T3 (fr)
HU (1) HU209311B (fr)
IL (1) IL92102A (fr)
NO (1) NO301074B1 (fr)
PH (1) PH27239A (fr)
PT (1) PT92140B (fr)
ZA (1) ZA898026B (fr)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0356595A1 (fr) * 1988-09-01 1990-03-07 Merrell Dow Pharmaceuticals Inc. Inhibiteurs des peptidases
CA2021660A1 (fr) * 1989-07-26 1991-01-27 Philippe Bey Inhibiteurs de la peptidose
IE902944A1 (en) * 1989-09-05 1991-03-13 Abbott Lab Peptidyl difluorodiol renin inhibitors
US5714470A (en) 1991-08-22 1998-02-03 Merrell Pharmaceuticals, Inc. Orally-active elastase inhibitors
US5478811A (en) * 1991-08-22 1995-12-26 Merrell Dow Pharmaceuticals Inc. Orally-active elastase inhibitors
NZ287604A (en) * 1994-06-02 1998-12-23 Merrell Pharma Inc Acylated enol derivatives as prodrugs of elastase inhibitors
EP0763055B1 (fr) * 1994-06-02 1999-11-03 Merrell Pharmaceuticals Inc. Inhibiteurs d'elastase au perfluoroalkyle cetone et procedes de production associes
US6172044B1 (en) 1995-12-01 2001-01-09 Aventis Pharmaceuticals Inc. Acylated enol derivative of α-ketoesters and α-ketoamides
US5948886A (en) * 1996-11-20 1999-09-07 Hoechst Marion Roussel, Inc. Acylated enol derivatives of α-ketoesters and α-ketoamides
EP2314598A1 (fr) * 1996-10-18 2011-04-27 Vertex Pharmaceuticals Incorporated Inhibiteurs de la protéase NS3 du virus de l'hépatite C
PE20050374A1 (es) 2003-09-05 2005-05-30 Vertex Pharma Inhibidores de proteasas de serina, en particular proteasa ns3-ns4a del vhc
FR2914920B1 (fr) 2007-04-11 2011-09-09 Clariant Specialty Fine Chem F Procede de deacetalisation d'alpha-aminoacetals.

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4518528A (en) * 1983-05-19 1985-05-21 Rasnick David W α Amino fluoro ketones
AU600226B2 (en) * 1985-02-04 1990-08-09 Merrell Pharmaceuticals Inc. Novel peptidase inhibitors
WO1986006379A1 (fr) * 1985-04-19 1986-11-06 The Upjohn Company Inhibiteurs de renine a substitution dihalo-statine
DE3683541D1 (de) * 1985-06-07 1992-03-05 Ici America Inc Selektionierte difluorverbindungen.
EP0258289A4 (en) * 1986-01-16 1991-01-02 Joseph Dellaria Peptide analogs
ES2052560T3 (es) * 1986-06-05 1994-07-16 Ici America Inc Compuestos difluorcetonicos.
NZ223148A (en) * 1987-01-16 1989-10-27 Merrell Dow Pharma Peptide derivatives having peptidase inhibition activity

Also Published As

Publication number Publication date
CN1043504A (zh) 1990-07-04
AU4386789A (en) 1990-05-03
DK537589A (da) 1990-04-29
US5114927A (en) 1992-05-19
FI895109A0 (fi) 1989-10-27
FI95272B (fi) 1995-09-29
PH27239A (en) 1993-05-04
NO301074B1 (no) 1997-09-08
HU209311B (en) 1994-04-28
CA2001265A1 (fr) 1990-04-28
CA2001265C (fr) 2001-05-01
ATE147405T1 (de) 1997-01-15
EP0368719A3 (fr) 1991-10-02
ES2099072T3 (es) 1997-05-16
IL92102A0 (en) 1990-07-12
DK537589D0 (da) 1989-10-27
HUT51649A (en) 1990-05-28
DE68927630D1 (de) 1997-02-20
AU622723B2 (en) 1992-04-16
CN1031880C (zh) 1996-05-29
NO894300L (no) 1990-04-30
HU895473D0 (en) 1990-01-28
EP0368719A2 (fr) 1990-05-16
PT92140B (pt) 1996-03-29
PT92140A (pt) 1990-04-30
JP2899327B2 (ja) 1999-06-02
GR3023027T3 (en) 1997-07-30
JPH02172961A (ja) 1990-07-04
ZA898026B (en) 1990-07-25
EP0371179A1 (fr) 1990-06-06
FI95272C (fi) 1996-01-10
EP0368719B1 (fr) 1997-01-08
NO894300D0 (no) 1989-10-27
DE68927630T2 (de) 1997-06-12

Similar Documents

Publication Publication Date Title
KR890003602B1 (ko) 옥사-및 아자호모사이클로스타틴 폴리펩티드의 제조방법
AU698239B2 (en) Tachykinin antagonists
EP0517589B1 (fr) Dérivés de tachykinines, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent
AU614272B2 (en) Novel peptidase inhibitors
EP0362002B1 (fr) Inhibiteurs de protease HIV
HU207869B (en) Process for producing nor-statin and nor-cyclostatin containing polypeptides
FR2575753A1 (fr) Nouveaux derives peptidiques a structure polycyclique azotee, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
AU8233491A (en) Retroviral protease inhibitors
NO169543B (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive peptidaseinhibitorer
JPH0342271B2 (fr)
US5114927A (en) Analog of peptidase substrates
WO1992000948A1 (fr) Inhibiteurs de proteases retrovirales
IE910146A1 (en) Orally active renin inhibitors
CH646415A5 (fr) Tetrapeptides homologues des enkephalines, leur preparation et composition pharmaceutique les contenant.
KR0139535B1 (ko) 신규 펩티다제 억제제
CA1336349C (fr) Tripeptides a structure polycyclique azotee, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
BE1005720A3 (fr) Procede de synthese peptidique et nouveaux intermediaires de synthese.
HU185230B (en) Process for producing pharmacologically active encephaline analogous peptides
WO1990007521A1 (fr) Inhibiteurs de renine contenant des amides dihydroxy a terminaison c
KR0144864B1 (ko) 신규한 펩티다제 기질 유사체
AU738114B2 (en) Process for the preparation of azacycloalkylalkanoyl pseudotetrapeptides
JPH0578290A (ja) ホモキラルα−アミノアルデヒドのジアステレオ選択的な還元的ピナコールカツプリング法
JPS6178795A (ja) レニン阻害ペプチド誘導体

Legal Events

Date Code Title Description
KB Patent renewed
KB Patent renewed
HC Change of name of proprietor(s)

Owner name: AVENTIS INC.

Free format text: FORMER NAME:MERRELL PHARMACEUTICALS INC.

MM9K Patent not in force due to non-payment of renewal fees